S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
NASDAQ:IRTC

iRhythm Technologies - IRTC Stock Forecast, Price & News

$121.21
+1.98 (+1.66%)
(As of 03/24/2023 05:31 PM ET)
Add
Compare
Today's Range
$117.57
$121.55
50-Day Range
$96.26
$120.25
52-Week Range
$85.74
$169.54
Volume
261,659 shs
Average Volume
354,719 shs
Market Capitalization
$3.66 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$146.36

iRhythm Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
22.4% Upside
$146.36 Price Target
Short Interest
Bearish
7.05% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.41mentions of iRhythm Technologies in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$1.33 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.86) to ($2.23) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.66 out of 5 stars

Medical Sector

852nd out of 989 stocks

Surgical & Medical Instruments Industry

86th out of 99 stocks


IRTC stock logo

About iRhythm Technologies (NASDAQ:IRTC) Stock

iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Stock News Headlines

4 Stocks With Huge Cash Holdings at Silicon Valley Bank (IRTC)
How the recent failure of Silicon Valley Bank leaves several companies with significant deposits stuck in the bank. Will regulators step in and save the day?
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
Where iRhythm Technologies Stands With Analysts
IRhythm Technologies
See More Headlines
Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Company Calendar

Last Earnings
2/23/2023
Today
3/24/2023
Next Earnings (Estimated)
5/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRTC
Fax
N/A
Employees
1,793
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$146.36
High Stock Price Forecast
$190.00
Low Stock Price Forecast
$105.00
Forecasted Upside/Downside
+22.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Net Income
$-116,150,000.00
Pretax Margin
-28.20%

Debt

Sales & Book Value

Annual Sales
$410.92 million
Book Value
$7.96 per share

Miscellaneous

Free Float
29,720,000
Market Cap
$3.60 billion
Optionable
Optionable
Beta
1.41

Key Executives

  • Quentin S. Blackford
    President, Chief Executive Officer & Director
  • Douglas J. DevineDouglas J. Devine
    Chief Operating Officer
  • Brice Bobzien
    Chief Financial Officer
  • Mark J. DayMark J. Day
    Chief Technology Officer
  • Mintu Turakhia
    Chief Medical & Scientific Officer













IRTC Stock - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" IRTC shares.
View IRTC analyst ratings
or view top-rated stocks.

What is iRhythm Technologies' stock price forecast for 2023?

10 equities research analysts have issued 12 month target prices for iRhythm Technologies' stock. Their IRTC share price forecasts range from $105.00 to $190.00. On average, they anticipate the company's share price to reach $146.36 in the next twelve months. This suggests a possible upside of 22.9% from the stock's current price.
View analysts price targets for IRTC
or view top-rated stocks among Wall Street analysts.

How have IRTC shares performed in 2023?

iRhythm Technologies' stock was trading at $93.67 on January 1st, 2023. Since then, IRTC stock has increased by 27.1% and is now trading at $119.08.
View the best growth stocks for 2023 here
.

Are investors shorting iRhythm Technologies?

iRhythm Technologies saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 2,130,000 shares, an increase of 6.0% from the February 13th total of 2,010,000 shares. Based on an average trading volume of 326,200 shares, the short-interest ratio is presently 6.5 days.
View iRhythm Technologies' Short Interest
.

When is iRhythm Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our IRTC earnings forecast
.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) released its quarterly earnings results on Thursday, February, 23rd. The company reported ($0.67) earnings per share for the quarter, missing the consensus estimate of ($0.63) by $0.04. The firm earned $112.62 million during the quarter, compared to analysts' expectations of $110.62 million. iRhythm Technologies had a negative trailing twelve-month return on equity of 35.85% and a negative net margin of 28.27%.

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies issued an update on its FY 2023 earnings guidance on Thursday, February, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $475.00 million-$485.00 million, compared to the consensus revenue estimate of $485.60 million.

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Sands Capital Management LLC (8.86%), Artisan Partners Limited Partnership (4.64%), LTS One Management LP (4.25%), Mackenzie Financial Corp (4.14%), Alliancebernstein L.P. (4.07%) and JPMorgan Chase & Co. (3.76%). Insiders that own company stock include Daniel G Wilson, David A Vort, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy, Quentin S Blackford, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends
.

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $119.08.

How much money does iRhythm Technologies make?

iRhythm Technologies (NASDAQ:IRTC) has a market capitalization of $3.60 billion and generates $410.92 million in revenue each year. The company earns $-116,150,000.00 in net income (profit) each year or ($3.89) on an earnings per share basis.

How many employees does iRhythm Technologies have?

The company employs 1,793 workers across the globe.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The official website for the company is www.irhythmtech.com. The company can be reached via phone at (415) 632-5700 or via email at investors@irhythmtech.com.

This page (NASDAQ:IRTC) was last updated on 3/24/2023 by MarketBeat.com Staff